Objective: The objective of this study is to determine the safety and tolerability of
Post-exposure Prophylaxis (PEP) with a regimen of Truvada + Kaletra among health care workers
(HCWs) at Henry Ford Hospital.
Hypothesis: Raltegravir is safe and better tolerated compared with Kaletra, each in
combination with Truvada, as assessed by review of completion rates of PEP and also review of
completed safety data.